论文部分内容阅读
目的:观察稳心律合剂治疗永久性房颤的疗效。方法:40例永久性心房颤动心阳不振证患者,随机分为稳心律合剂组和对照组各20例,观察周期28d,采用中华生存质量量表(ChQOL)、心悸证候学评分表进行治疗前后的评分。结果:稳心律合剂组较对照组在生存质量第一维度“睡眠”、“饮食消化”和“眼神”以及第二维度“形”、“总体主观健康”上的改善更为明显;稳心律合剂组较对照组证候改善更为明显。结论:运用ChQOL评估稳心律合剂疗效的可行性,仍需进一步检验;中医药疗效评估需要更合适的体系,循证医学方法及终点指标、生存质量、患者报告结果等均值得借鉴。
Objective: To observe the effect of Wenxinkeli Mixture in the treatment of permanent atrial fibrillation. Methods: Forty patients with permanent atrial fibrillation with cardioangiopancreatic syndrome were randomly divided into two groups, 20 cases in each group. The observation period was 28 days. ChQOL and palpitation syndrome score The score before and after treatment. Results: Compared with the control group, the Wenshenli Mixture group had significant differences in the first dimension of quality of life “sleep”, “diet digestion” and “eye”, as well as the second dimension “shape”, “overall subjective health” The improvement is more obvious; Wenxinlixikeli group is more obvious than the control group syndrome. Conclusions: The feasibility of using ChQOL to evaluate the efficacy of Wenxionglixie agent still needs to be further tested. Evaluation of efficacy of TCM requires a more appropriate system, evidence-based medical methods and end point indicators, quality of life, and patient reporting results.